Cardiac Science Corporation is committed to supporting innovative research in cardiac diagnosis and care. We are excited to advance the cardiology industry's breadth of knowledge in effectively identifying patients at risk of cardiovascular death -- the number one cause of death in the United States. |
These new patents expand the entire body of intellectual property surrounding the company's devices and technology. |
Working with GE, our engineering team has developed a streamlined, feature-rich device that is extremely intuitive and easy to use, extending our already broad technology portfolio to the traditional hospital defibrillator market. Our agreements with GE will enable effective access to the estimated $300 million in annual worldwide demand for hospital defibrillator-monitors. |